Literature DB >> 24942827

The use of non-narcotic pain medication in pediatric gastroenterology.

Adrian Miranda1, Miguel Saps.   

Abstract

The perception of pain in children is easily influenced by environmental factors and psychological comorbidities that are known to play an important role in its origin and response to therapy. Chronic abdominal pain is one of the most commonly treated conditions in modern pediatric gastroenterology and is the hallmark of 'functional' disorders that include irritable bowel syndrome, functional dyspepsia, and functional abdominal pain. The development of pharmacological therapies for these disorders in adults and children has been limited by the lack of understanding of the putative, pathophysiological mechanisms that underlie them. Peripheral and central pain-signaling mechanisms are known to be involved in chronic pain originating from the gastrointestinal tract, but few therapies have been developed to target specific pathways or enhance correction of the underlying pathophysiology. The responses to therapy have been variable, potentially reflecting the heterogeneity of the disorders for which they are used. Only a few small, randomized clinical trials have evaluated the benefit of pain medications for chronic abdominal pain in children and thus, the decision on the most appropriate treatment is often based on adult studies and empirical data. This review discusses the most common, non-narcotic pharmacological treatments for chronic abdominal pain in children and includes a thorough review of the literature to support or refute their use. Because of the dearth of pediatric studies, the focus is on pharmacological and alternative therapies where there is sufficient evidence of benefit in either adults or children with chronic abdominal pain.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24942827     DOI: 10.1007/s40272-014-0080-6

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN: 1174-5878            Impact factor:   3.022


  150 in total

1.  Brain responses to visceral stimuli reflect visceral sensitivity thresholds in patients with irritable bowel syndrome.

Authors:  Mats B O Larsson; Kirsten Tillisch; A D Craig; Maria Engström; Jennifer Labus; Bruce Naliboff; Peter Lundberg; Magnus Ström; Emeran A Mayer; Susanna A Walter
Journal:  Gastroenterology       Date:  2011-11-19       Impact factor: 22.682

2.  A comparative study of loratadine syrup and cyproheptadine HCL solution for treating perennial allergic rhinitis in Taiwanese children aged 2-12 years.

Authors:  K G Wu; T H Li; T Y Wang; C L Hsu; C J Chen
Journal:  Int J Immunopathol Pharmacol       Date:  2012 Jan-Mar       Impact factor: 3.219

3.  Melatonin reversal of lipopolysacharides-induced thermal and behavioral hyperalgesia in mice.

Authors:  V Raghavendra; J N Agrewala; S K Kulkarni
Journal:  Eur J Pharmacol       Date:  2000-04-21       Impact factor: 4.432

4.  Autonomic nervous system function in young children with functional abdominal pain or irritable bowel syndrome.

Authors:  Monica Jarrett; Margaret Heitkemper; Danita Czyzewski; Lonnie Zeltzer; Robert J Shulman
Journal:  J Pain       Date:  2012-04-20       Impact factor: 5.820

5.  International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefit.

Authors:  Douglas A Drossman; Carolyn Blank Morris; Susan Schneck; Yuming J B Hu; Nancy J Norton; William F Norton; Stephan R Weinland; Christine Dalton; Jane Leserman; Shrikant I Bangdiwala
Journal:  J Clin Gastroenterol       Date:  2009-07       Impact factor: 3.062

Review 6.  Trimebutine: mechanism of action, effects on gastrointestinal function and clinical results.

Authors:  M Delvaux; D Wingate
Journal:  J Int Med Res       Date:  1997 Sep-Oct       Impact factor: 1.671

7.  Effects of pregabalin on visceral pain responses and colonic compliance in rats.

Authors:  A Ravnefjord; M Brusberg; H Larsson; E Lindström; V Martínez
Journal:  Br J Pharmacol       Date:  2008-06-23       Impact factor: 8.739

8.  Effect of a chloride channel activator, lubiprostone, on colonic sensory and motor functions in healthy subjects.

Authors:  Seth Sweetser; Irene A Busciglio; Michael Camilleri; Adil E Bharucha; Lawrence A Szarka; Athanasios Papathanasopoulos; Duane D Burton; Deborah J Eckert; Alan R Zinsmeister
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-11-25       Impact factor: 4.052

9.  Intrathecal amitriptyline acts as an N-methyl-D-aspartate receptor antagonist in the presence of inflammatory hyperalgesia in rats.

Authors:  J C Eisenach; G F Gebhart
Journal:  Anesthesiology       Date:  1995-11       Impact factor: 7.892

10.  Management of irritable bowel syndrome in primary care: the results of an exploratory randomised controlled trial of mebeverine, methylcellulose, placebo and a self-management website.

Authors:  Hazel Everitt; Rona Moss-Morris; Alice Sibelli; Laura Tapp; Nicholas Coleman; Lucy Yardley; Peter Smith; Paul Little
Journal:  BMC Gastroenterol       Date:  2013-04-21       Impact factor: 3.067

View more
  2 in total

1.  Persistent Opioid Use Among Children, Adolescents, and Young Adults After Common Cleft Operations.

Authors:  Katelyn G Bennett; Calista M Harbaugh; Hsou Mei Hu; Christian J Vercler; Steven R Buchman; Chad M Brummett; Jennifer F Waljee
Journal:  J Craniofac Surg       Date:  2018-10       Impact factor: 1.046

Review 2.  Stress-Induced Chronic Visceral Pain of Gastrointestinal Origin.

Authors:  Beverley Greenwood-Van Meerveld; Anthony C Johnson
Journal:  Front Syst Neurosci       Date:  2017-11-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.